Ibandronate Clinical Trials

• A study to assess the efficacy and safety of 100 mg and 150 mg monthly oral ibandronate in women with postmenopausal osteoporosis having completed the phase III oral ibandronate trial
  ClinicalTrials.gov Identifier: NCT00081653 - Active, not recruiting
  Osteoporosis
  
• A Study To Assess The Quality Of Bone In Patients Taking Oral Ibandronate Versus Placebo
  ClinicalTrials.gov Identifier: NCT00148915 - Active, not recruiting
  Osteoporosis
  
• A Study to Examine the Effectiveness and Safety of Oral Ibandronate Given Once Monthly in Postmenopausal Women with Osteopenia
  ClinicalTrials.gov Identifier: NCT00129623 - Active, not recruiting
  Bone Disease, Metabolic; Osteopenia
  
• Impact of Oral Ibandronate 150mg Monthly on Structural Properties of Bone in Postmenopausal Osteoporosis (SPIMOS-3D)
  ClinicalTrials.gov Identifier: NCT00271713 - Active, not recruiting
  Osteoporosis, Postmenopausal
  
• Efficacy and safety study of intravenous ibandronate to treat postmenopausal osteoporosis as compared to daily oral ibandronate
  ClinicalTrials.gov Identifier: NCT00048074 - Completed
  Osteoporosis
  
• Single-Dose Local Radiation Therapy Compared With Ibandronate in Treating Patients With Localized Metastatic Bone Pain
  ClinicalTrials.gov Identifier: NCT00082927 - Recruiting
  Breast Cancer; Lung Cancer; metastatic cancer; Pain; Prostate Cancer
  
• A Study of Adherence to Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis, Supported by a Patient Relationship Program (PRP)
  ClinicalTrials.gov Identifier: NCT00545363 - Active, not recruiting
  Post-Menopausal Osteoporosis
  
• A Study Comparing Monthly Boniva (Ibandronate) and Weekly Risedronate in Women With Post-Menopausal Osteoporosis.
  ClinicalTrials.gov Identifier: NCT00377234 - Active, not recruiting
  Post-Menopausal Osteoporosis
  
• A Study of Quarterly Intravenous Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.
  ClinicalTrials.gov Identifier: NCT00493532 - Active, not recruiting
  Post-Menopausal Osteoporosis
  
• Ibandronate Versus Placebo in the Prevention of Bone Loss After Renal Transplantation.
  ClinicalTrials.gov Identifier: NCT00423384 - Recruiting
  Renal Transplant
  
• A Study of Once Monthly Bonviva (Ibandronate) in Prevention of Glucocorticoid-Induced Osteoporosis.
  ClinicalTrials.gov Identifier: NCT00545051 - Recruiting
  Post-Menopausal Osteoporosis
  
• Zoledronate, Clodronate, or Ibandronate in Treating Women Who Have Undergone Surgery for Stage I, Stage II, or Stage III Breast Cancer
  ClinicalTrials.gov Identifier: NCT00127205 - Recruiting
  stage I breast cancer; stage II breast cancer; stage IIIA breast cancer; stage IIIB breast cancer; stage IIIC breast cancer
  
• The Effect of Oral Ibandronate in Male Osteoporosis
  ClinicalTrials.gov Identifier: NCT00397839 - Recruiting
  Osteoporosis
  
• The Effects of Ibandronate or Teriparatide Therapy on Bone Histology and Biochemical Indices in Patients on Hemodialysis With Low Bone Mineral Density
  ClinicalTrials.gov Identifier: NCT00446589 - Recruiting
  Osteoporosis
  
• SUMMIT Study: A Study of Persistence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis.
  ClinicalTrials.gov Identifier: NCT00545480 - Active, not recruiting
  Post-Menopausal Osteoporosis
  
• BEATRIS Study: A Study of Adherence to Bonviva (Ibandronate) Once Monthly in Women With Post-Menopausal Osteoporosis
  ClinicalTrials.gov Identifier: NCT00545909 - Active, not recruiting
  Post-Menopausal Osteoporosis
  
• A Study of Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis Who Have Received Previous Bonviva Treatment
  ClinicalTrials.gov Identifier: NCT00551174 - Active, not recruiting
  Post-Menopausal Osteoporosis
  
• ExBonAdAsia Study: A Study of Once Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis.
  ClinicalTrials.gov Identifier: NCT00545090 - Active, not recruiting
  Post-Menopausal Osteoporosis
  
• A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Metastatic Bone Disease.
  ClinicalTrials.gov Identifier: NCT00478270 - Recruiting
  Pain;; Bone Neoplasms;; Neoplasm Metastasis
  
• A Study of Loading Doses of Intravenous Bondronat (Ibandronate) in Patients With Breast Cancer and Malignant Bone Disease.
  ClinicalTrials.gov Identifier: NCT00502736 - Recruiting
  Pain;; Bone Neoplasms;; Neoplasm Metastasis
  
• Study To Investigate Patient Preference On Dosing In Ibandronate And Risedronate In Korean Women With Postmenopausal Osteoporosis
  ClinicalTrials.gov Identifier: NCT00405392 - Recruiting
  Postmenopausal Osteoporosis
  
• BONDIR Study: A Study of Intravenous Bonviva (Ibandronate) After Recent Vertebral Osteoporotic Fracture in Patients With Osteoporosis.
  ClinicalTrials.gov Identifier: NCT00493623 - Recruiting
  Osteoporosis
  
• A Study to Compare ETC vs. EC-TX and Ibandronate vs. Observation in Patients With Node-Positive Primary Breast Cancer
  ClinicalTrials.gov Identifier: NCT00196872 - Recruiting
  Breast Cancer
  
• Safety and Efficacy Study of Intravenous Loading Dose of Ibandronate in Breast Cancer Patients
  ClinicalTrials.gov Identifier: NCT00381368 - Recruiting
  Breast Cancer
  
• A Study of Bonviva (Ibandronate) and Alendronate on Renal Function in Postmenopausal Women With Osteoporosis at High Risk for Renal Disease.
  ClinicalTrials.gov Identifier: NCT00503113 - Recruiting
  Post-Menopausal Osteoporosis
  
• Ibandronate or Zoledronate in Treating Patients With Newly Diagnosed Bone Metastases From Breast Cancer
  ClinicalTrials.gov Identifier: NCT00326820 - Recruiting
  Breast Cancer; Hypercalcemia; Metastatic Cancer
  
• A Study of Bonviva (Ibandronate) Once Monthly in Post-Menopausal Women With Osteopenia.
  ClinicalTrials.gov Identifier: NCT00545207 - Recruiting
  Post-Menopausal Osteopenia
  
• BONCURE Study: A Study of Monthly Bonviva (Ibandronate) in Women With Post-Menopausal Osteoporosis on Bisphosphonate Therapy.
  ClinicalTrials.gov Identifier: NCT00545779 - Recruiting
  Post-Menopausal Osteoporosis
  
• Study Into the Effect of Ibandronate for the Treatment of Bone Marrow Edema in Relation to Spontaneous or Non-Traumatic Osteonecrosis of the Knee: A Randomized Double-Blind, Placebo-Controlled Trial
  ClinicalTrials.gov Identifier: NCT00532220 - Recruiting
  Osteonecrosis of the Knee; Bone Marrow Edema of the Knee
  
• Loading Dose or Standard Dose of Intravenous Ibandronate in Treating Patients With Lung Cancer and Skeletal Metastasis
  ClinicalTrials.gov Identifier: NCT00492843 - Not yet recruiting
  Lung Cancer
  
• Evaluation Of Missed Osteoporosis Diagnoses, And Preference Between Once Monthly Ibandronate And Once Weekly Alendronate
  ClinicalTrials.gov Identifier: NCT00327990 - Completed
  Osteoporosis
  
• Efficacy and safety study of oral ibandronate to treat postmenopausal osteoporosis
  ClinicalTrials.gov Identifier: NCT00048061 - Completed
  Osteoporosis
  
• A Study of Bone Turnover Markers in Post-Menopausal Women With Osteoporosis Treated With Monthly Boniva (Ibandronate)
  ClinicalTrials.gov Identifier: NCT00303485 - Completed
  Post-Menopausal Osteoporosis
  
• Zoledronate or Ibandronate in Preventing Bone Problems in Women With Stage IV Breast Cancer That Has Spread to the Bone
  ClinicalTrials.gov Identifier: NCT00301886 - Completed
  Breast Cancer; Hypercalcemia; Metastatic Cancer; Pain; Quality of Life